Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sangamo Biosciences ( Ceregene )
ClinicalTrials.gov Identifier:
NCT00087789
First received: July 13, 2004
Last updated: October 27, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2010
  Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)